AffiliationNational Centre for Pharmacoeconomics, Dublin, Ireland.
MetadataShow full item record
CitationO'Connell K et al. Economic costs associated with an MS relapse. Multiple Sclerosis Rel Disord 2014 [published online 16 September 2014]
PublisherMultiple Sclerosis and Related Disorders
JournalMultiple Sclerosis and Related Disorders
AbstractThis was an prospective audit composed of medical chart review and patient questionnaire. Relapses were stratified into 3 groups: low, moderate and high intensity. Age, gender, MS subtype, disease duration, expanded disability status scale (EDSS) score, disease modifying therapy (DMT) use and employment status were recorded. Direct costs included GP visits, investigations, clinic visit, consultations with medical staff, medication and admission costs. Indirect costs assessed loss of earnings, partner's loss of earnings, childcare, meals and travel costs.